Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease

Iron deficiency, anemia, hyperphosphatemia, and increased fibroblast growth factor 23 (FGF23) are common and interrelated complications of chronic kidney disease (CKD) that are linked to CKD progression, cardiovascular disease and death. Ferric citrate is an oral phosphate binder that decreases diet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Int
Main Authors: Francis, Connor, Courbon, Guillaume, Gerber, Claire, Neuburg, Samantha, Wang, Xueyan, Dussold, Corey, Capella, Maralee, Qi, Lixin, Isakova, Tamara, Mehta, Rupal, Martin, Aline, Wolf, Myles, David, Valentin
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875640/
https://ncbi.nlm.nih.gov/pubmed/31668632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.07.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados